Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $13.9100 (1.76%) ($13.5300 - $13.9900) on Mon. Jul. 20, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.73% (three month average) | RSI | 53 | Latest Price | $13.9100(1.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.5% a day on average for past five trading days. | Weekly Trend | ATRA declines -3.8% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(44%) IBB(44%) IWO(44%) ARKK(43%) | Factors Impacting ATRA price | ATRA will decline at least -3.365% in a week (0% probabilities). VIXM(-32%) VXX(-26%) XLC(-10%) UNG(-9%) UUP(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.365% (StdDev 6.73%) | Hourly BBV | 0 () | Intraday Trend | 1.5% | | | |
|
Resistance Level | $14.07 | 5 Day Moving Average | $13.68(1.68%) | 10 Day Moving Average | $14.24(-2.32%) | 20 Day Moving Average | $14.07(-1.14%) | To recent high | -10.3% | To recent low | 75.6% | Market Cap | $1.034b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |